What is Nuvation Bio's D&A?

Nuvation Bio (NUVB) reported D&A of $536K in Q1 2026.

How has Nuvation Bio's D&A changed year-over-year?

Nuvation Bio's D&A increased by 72.9% year-over-year, from $310K to $536K.

What is the long-term trend for Nuvation Bio's D&A?

Over 4 years (2021 to 2025), Nuvation Bio's D&A has grown at a 75.3% compound annual growth rate (CAGR), from $184K to $1.74M.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Nuvation Bio NUVB D&A

D&A at other companies

Bristol-Myers SquibbBMY

$594M-41.3%

PfizerPFE

$1.61B-0.3%

ImmunomeIMNM

$603K-1.3%

ArriVent BioPharma, Inc.AVBP

-$559K+26.1%

Arcus BiosciencesRCUS

$2M-33.3%

IDEAYA Biosciences, Inc.IDYA

$688K+14.7%

Other financials

Income statement

See full

Revenue$83.2M+2,599%

Gross profit$9.8M+1,340%

Operating income$3.9M+107%

Net income$5.4M+110%

EPS (diluted)$0.01+106%

Balance sheet

See full

Cash & equivalents$125.4M+161%

Total debt$57.2M+401%

Total equity$319.6M-23.8%

Total assets$610.2M+23.9%

Cash flow

See full

Operating cash flow$5.1M+112%

CapEx$48.0K-33.3%

Free cash flow$5.0M+112%

Valuation

See full

Market cap$2.1B+150%

Enterprise value$2.03B+154%

P/S14.7×-62.0×

Profitability

See full

Gross margin54.3%+39.5pp

Operating margin-105%-52.0pp

Net margin-102.1%-50.6pp

FCF margin-93.5%-45.2pp

Returns & leverage

See full

Return on equity-39.5%-15.8pp

Debt / equity0.2×+0.2×

Current ratio7.4×-1.6×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nuvation Bio's D&A?: Nuvation Bio (NUVB) reported D&A of $536K in Q1 2026.
How has Nuvation Bio's D&A changed year-over-year?: Nuvation Bio's D&A increased by 72.9% year-over-year, from $310K to $536K.
What is the long-term trend for Nuvation Bio's D&A?: Over 4 years (2021 to 2025), Nuvation Bio's D&A has grown at a 75.3% compound annual growth rate (CAGR), from $184K to $1.74M.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.